Parallax Volatility Advisers, L.P. Sorrento Therapeutics, Inc. Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.23 $195 - $303	-42 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.23 $7,877 - $12,247	-1,694 Reduced 97.58%	42 $0
Q4 2020 Feb 16, 2021	BUY	$5.76 - $11.95 $9,999 - $20,745	1,736 New	1,736 $12,000
Q4 2020 Feb 16, 2021	SELL	$5.76 - $11.95 $105,626 - $219,139	-18,338 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$6.17 - $18.82 $113,145 - $345,121	18,338 New	18,338 $204,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.